If a 2005 tape featuring current Republican presidential nominee Donald Trump rattled people across the country with its use of misogynistic language that promoted sexual assault, it also scared biotech investors — albeit for different reasons.
A biotech selloff since the tape’s early-October release has cost investors $50 billion and caused them “obvious concern” about the double whammy of both a Democrat president and Democrat-controlled Congress, according to a new report by Leerink Partners.
